{
    "Trade/Device Name(s)": [
        "Carbon Dioxide"
    ],
    "Submitter Information": "Abbott Laboratories",
    "510(k) Number": "K060295",
    "Predicate Device Reference 510(k) Number(s)": [
        "K032377"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "KHS"
    ],
    "Summary Letter Date": "February 3, 2006",
    "Summary Letter Received Date": "February 15, 2006",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR862.1160"
    ],
    "Regulation Name(s)": [
        "Bicarbonate/carbon dioxide test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Carbon Dioxide",
        "Bicarbonate"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "AEROSET System",
        "ARCHITECT c8000 System",
        "Hitachi 717 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzymatic assay",
        "Phosphoenolpyruvate carboxylase method"
    ],
    "Methodologies": [
        "Quantitative enzymatic analysis"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent",
        "Calibrator",
        "Test system"
    ],
    "Document Summary": "FDA 510(k) summary for Abbott Laboratories Carbon Dioxide quantitative enzymatic assay on serum and plasma using AEROSET and ARCHITECT platforms.",
    "Indications for Use Summary": "Intended to measure bicarbonate/carbon dioxide in plasma and serum; used in diagnosis and treatment of disorders associated with changes in body acid-base balance.",
    "fda_folder": "Clinical Chemistry"
}